Symic Biomedical reports MODIFY2 phase II trial results of SB-061 for knee osteoarthritis Feb. 8, 2018
YL Biologics reports successful completion of phase III trial of etanercept biosimilar YLB-113 Feb. 8, 2018
Anika Therapeutics collaborates with University of Liverpool on MSC therapy for osteoarthritis Feb. 2, 2018
Pfizer enrolling patients in phase II study of PF-06823859 in moderate to severe dermatomyositis Feb. 2, 2018
RSS